Novel Preclinical Drug Could Have Potential to Combat Depression, Brain Injury, and Cognitive Disorders - Neuroscience News
5/20/2022 12:00:00 AM2 years 11 months ago
by https://www.facebook.com/neurosciencenews
by https://www.facebook.com/neurosciencenews
A preclinical drug that inhibits the kinase enzyme Cdk5 may have the potential to treat depression, brain injuries, and disorders associated with cognitive impairment.
Summary: A preclinical drug that inhibits the kinase enzyme Cdk5 may have the potential to treat depression, brain injuries, and disorders associated with cognitive impairment. Source: University of… [+5215 chars]
full article...